NCT04463212View on ClinicalTrials.gov

Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

January 12, 2024

Study Completion Date

January 12, 2024

Conditions
Reversible Cerebral Vasoconstriction Syndrome
Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT04463212 - Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome | Biotech Hunter | Biotech Hunter